Hubbell Lab

Kiyomitsu Katsumata

Kiyomitsu received his PhD at Tohoku University in Japan and is currently a pharmacologist of the pharmaceutical company Astellas Pharma Inc.

Drug targeting for suppression of inflammation in murine models of autoimmunity.